bioAffinity Technologies, Inc. (NASDAQ:BIAF) Sees Large Drop in Short Interest

bioAffinity Technologies, Inc. (NASDAQ:BIAF) was the target of a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 114,000 shares, a drop of 35.8% from the December 15th total of 177,500 shares. Approximately 1.2% of the company’s shares are short sold. Based on an average daily volume of 150,600 shares, the short-interest ratio is currently 0.8 days.

bioAffinity Technologies Price Performance

Shares of bioAffinity Technologies stock opened at $0.76 on Wednesday. The stock has a market cap of $11.81 million, a price-to-earnings ratio of -0.92 and a beta of 2.98. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.01 and a current ratio of 1.02. The stock has a 50 day moving average price of $1.07 and a 200-day moving average price of $1.61. bioAffinity Technologies has a one year low of $0.67 and a one year high of $3.62.

About bioAffinity Technologies

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.